To include your compound in the COVID-19 Resource Center, submit it here.

BNC105: Interim Phase I/II data

Interim data from the Phase I portion of an open-label, dose-escalation, U.S. Phase I/II trial in patients who failed

Read the full 194 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE